ArticleFrontiers in immunology2023

Satralizumab as an add-on treatment in refractory pediatric AQP4-antibody-positive neuromyelitis optica spectrum disorder: a case report.

Xiaojing Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.